Literature DB >> 32046624

Nasal formulations for drug administration and characterization of nasal preparations in drug delivery.

Regina Scherließ1.   

Abstract

This special report gives an insight in the rationale of utilizing the nasal cavity for drug administration and the formulation as well as characterization of nasal preparations. As the nose is an easy-to-access, noninvasive and versatile location for absorption, this route of delivery will play an increasingly important role in future drug product development both for new and repurposed drugs. The nose can be utilized for local and systemic delivery including drug delivery to the central nervous system and the immune system. Typical formulation strategies and future developments are reviewed, which nowadays mostly comprise liquid formulations. Although they are straight forward to develop, a number of aspects from choice of solvent, osmolarity, pH, viscosity and more need to be considered, which determine formulation characteristics, not at least nasal deposition. Nasal powders offer higher stability and, along with more sophisticated nasal devices, may play a major role in the future.

Keywords:  Repurposing of drugs; device; formulation parameters; nasal deposition; nasal vaccines; nose-to-brain delivery; pharmacopoeial requirements

Mesh:

Substances:

Year:  2020        PMID: 32046624     DOI: 10.4155/tde-2019-0086

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  8 in total

1.  Intranasal Delivery of Darunavir-Loaded Mucoadhesive In Situ Gel: Experimental Design, In Vitro Evaluation, and Pharmacokinetic Studies.

Authors:  Anroop B Nair; Sunita Chaudhary; Hiral Shah; Shery Jacob; Vivek Mewada; Pottathil Shinu; Bandar Aldhubiab; Nagaraja Sreeharsha; Katharigatta N Venugopala; Mahesh Attimarad; Jigar Shah
Journal:  Gels       Date:  2022-05-30

2.  Instillation of a Dry Powder in Nasal Casts: Parameters Influencing the Olfactory Deposition With Uni- and Bi-Directional Devices.

Authors:  Clément Rigaut; Laura Deruyver; Jonathan Goole; Benoît Haut; Pierre Lambert
Journal:  Front Med Technol       Date:  2022-06-27

Review 3.  Nasal vaccine as a booster shot: a viable solution to restrict pandemic?

Authors:  Sarasa Meenakshi; V Udaya Kumar; Sameer Dhingra; Krishna Murti
Journal:  Clin Exp Vaccine Res       Date:  2022-05-31

4.  Quality by Design Based Formulation Study of Meloxicam-Loaded Polymeric Micelles for Intranasal Administration.

Authors:  Bence Sipos; Piroska Szabó-Révész; Ildikó Csóka; Edina Pallagi; Dorina Gabriella Dobó; Péter Bélteky; Zoltán Kónya; Ágota Deák; László Janovák; Gábor Katona
Journal:  Pharmaceutics       Date:  2020-07-24       Impact factor: 6.321

Review 5.  Intranasal drug delivery: opportunities and toxicologic challenges during drug development.

Authors:  Lea-Adriana Keller; Olivia Merkel; Andreas Popp
Journal:  Drug Deliv Transl Res       Date:  2021-01-25       Impact factor: 4.617

6.  Cerebral and extracerebral distribution of radioactivity associated with oxytocin in rabbits after intranasal administration: Comparison of TTA-121, a newly developed oxytocin formulation, with Syntocinon.

Authors:  Daisuke Ishii; Michiharu Kageyama; Shin Umeda
Journal:  PLoS One       Date:  2021-12-20       Impact factor: 3.240

7.  A Novel Faster-Acting, Dry Powder-Based, Naloxone Intranasal Formulation for Opioid Overdose.

Authors:  Tair Lapidot; Mohammed Bouhajib; Janice Faulknor; Shabaz Khan; Galia Temtsin Krayz; Carolina Abrutzky; Dalia Megiddo
Journal:  Pharm Res       Date:  2022-04-06       Impact factor: 4.580

8.  Comparison of Modern In Vitro Permeability Methods with the Aim of Investigation Nasal Dosage Forms.

Authors:  Csilla Bartos; Piroska Szabó-Révész; Tamás Horváth; Patrícia Varga; Rita Ambrus
Journal:  Pharmaceutics       Date:  2021-06-08       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.